Compulsory licensing remains one of the most closely watched and debated areas of intellectual property law. While used infrequently in many jurisdictions, compulsory licences continue to play an important role in discussions surrounding access to technology, public policy, competition, public health, and the balance between exclusive rights and broader societal interests.
This category covers legal and policy developments relating to compulsory licences and other forms of non-voluntary licensing across patents, copyright, and related rights. Our contributors analyse legislative initiatives, court decisions, administrative actions, and international developments that influence how compulsory licensing frameworks are interpreted and applied in practice.
Topics covered include pharmaceutical and healthcare innovation, standard-essential patents (SEPs), competition law considerations, government use provisions, technology transfer, and emerging debates arising from the digital and green transitions. We also examine developments at the national, regional, and international level, including initiatives discussed within the World Trade Organization (WTO), World Intellectual Property Organization (WIPO), and other policymaking forums.
For IP professionals, policymakers, in-house counsel, and private practitioners, this section provides timely analysis of compulsory licensing developments and their implications for intellectual property strategy, innovation, and market access.
At the AIPPI, irony sometimes writes itself. In 2020, when the Association launched its essay competition, I submitted a paper on compulsory licenses and legitimacy — optimistically entitled “COVID…
The legal battles surrounding osimertinib have brought significant attention to the pharmaceutical industry in Russia, particularly in relation to intellectual property rights, competition laws, and…
The Court of Appeal’s judgment in Optis Cellular Technology LLC v Apple Retail UK Ltd [2025] EWCA Civ 552, handed down on 1 May 2025, is arguably the most significant UK FRAND decision since Unwired…
The refusal to grant a licence for intellectual property (IP) rights can sometimes conflict with competition law. This topic has already been explored in the case law of national courts and the Court…
On 18 September 2024, the Honourable Justice Jackman, in his capacity as a Deputy President of the Administrative Appeals Tribunal (AAT), granted Sandoz a licence pursuant to section 223(9) of the…
On May 30, 2024, the JPO announced that the request for a decision of granting a compulsory non-exclusive license based on public interest under Article 93 of the Patent Act, which was filed by…
In what will be seen as a welcome development to IP owners, the Brazilian Patent Office (BRPTO) is improving the system to record IP agreements.
More specifically, on 11 July 2023, the BRPTO…
In September 2021, Brazilian Congress passed a law changing the compulsory licensing landscape as a political answer to the impact of the Covid-19 pandemic. Initially, Congress wanted to include new…
On June 17, 2022, WTO members adopted a waiver to the WTO Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) allowing suspension of patent related to the Covid-19 pandemic,…